Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Ch... ( INDIANAPOLIS Nov. 28 /- Eli Lilly and...)

Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain

Date:11/28/2008

INDIANAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit the application in the first half of 2009, adding data from a recently completed positive study in chronic osteoarthritis pain of the knee.

The decision does not affect duloxetine's FDA-approved indications for major depressive disorder, generalized anxiety disorder, management of diabetic peripheral neuropathic pain and management of fibromyalgia.

Lilly submitted the chronic pain application in the second quarter of 2008 based primarily on outcomes of three clinical trials: one positive study in chronic osteoarthritis pain of the knee(i) and two studies(ii,iii), -- one positive and one that is supportive but didn't meet its primary endpoint -- in chronic low back pain. In discussions between Lilly and the FDA, agency reviewers raised questions about efficacy and dosing that revolved primarily around statistical methodology and study design.

"This was a difficult decision, but we believe the updated data package will give the FDA a broader basis for reviewing our application," said John Hayes, M.D., a Lilly Research Laboratories vice president at Lilly.

Chronic pain affects more than 50 million Americans(iv) and pain is a major cause of work absenteeism, underemployment and unemployment.(v,vi,vii,viii)

About Duloxetine

Serotonin and norepinephrine in the brain and spinal cord are believed to both mediate core mood symptoms and help regulate the perception of pain. Based on preclinical studies, Duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is bel
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement

Post Your Comments:

(Date:5/17/2013)... Biotech Ltd. (Nasdaq: SVA ), a leading provider ... that it will release its unaudited financial results for the ... May 28, 2013. The Company will host a conference call ... 28, 2013 at 8:00 p.m. China Standard Time) to review ... corporate developments. To access the conference call, please ...

(Date:5/16/2013)... Ill. and MECHELEN, Belgium ... GLPG) and AbbVie (NYSE: ABBV ) announced ... to include Crohn,s disease. Galapagos will fund and complete ... designed to facilitate rapid progression into Phase 3. Upon ... AbbVie will pay Galapagos $50 million. The terms of ...

(Date:5/16/2013)... N.C. , May 16, 2013 Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...

Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2 Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3

[0] Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results [0] AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease [0] National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill

... Epeius Biotechnologies,announced today the promising results of an on-going ... cancer that is refractory,to conventional chemotherapy (J Clin Oncol ... given i.v. two to,three times a week for 4 ... to 6,x 10e11 cfu per week. The goal of ...

... Communities for Drug Safety,Collaboration" conducting drug safety ... health information to support post-market monitoring efforts, ... eHealth,Initiative (eHI) announced today its support of ... (FDA) on the Sentinel Initiative, a,far-reaching public ...

Cached Medicine Technology:TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008) 2 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 2 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 3 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 4 eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative 5

TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative

(Date:5/20/2013)... May 20, 2013 Healing Heart Urgent ... newest office on Briarcliff Road in the Druid Hills ... facility includes Dr. Fidias E. De León M.D. and ... will provide extensive medical services, occupational health, chiropractic care ... Atlanta metropolitan area. They also offer a full range ...

(Date:5/20/2013)... 20, 2013 AURORA, Colo. – May ... accredited university, has developed a Bachelor of Science ... how they feel about continuing their education and gauge ... out the complimentary worksheet, respond to ten statements and ... rate on a BSN-readiness scale. , New industry standards ...

(Date:5/20/2013)... NY (PRWEB) May 20, 2013 InVite® ... City, today announced the introduction of its new ... that provides high density nutrition with plant extracts from ... herbs, spices, royal jelly, apple pectin, plant enzymes and ... offers the micronutrients and antioxidant levels of several servings ...

(Date:5/20/2013)... Can you tell a joke well? , Do people roll their ... like to be funnier as a speaker, teacher, presenter of any ... missing? , Can't think of a snappy comeback when someone hits ... like you, don't worry. Help is here. I believe ... even learn to tell a joke well. I am not kidding. ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 FixturesAndDisplays.com, the ... comprehensive selection of high-quality retail clothing display options to ... and upscale retailers. Their expansive product line includes ... broad range of mannequin options. Recently ... its most popular models in reformulated “green” versions. ...

Breaking Medicine News(10 mins):Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2 Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2 Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3 Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2 Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4 Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 2 Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 3

[0] Healing Heart Urgent Care Opens New Office In Atlanta [0] American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness [0] InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™[0] Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke [0] FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays

... , , , ... has been invited to participate in the inaugural Australian Paralympic ... basketball team includes nine athletes and three coaches from Courage ... 5-11 at the Melbourne Sports & Aquatic Centre. The Paralympic ...

... , WASHINGTON, Sept. 23 Speaker Nancy ... Legislative Conference "Capitol Hill Day Summit" this morning in the Capitol ... , , "Thank you, Chairwoman Barbara ... conscience of the Congress. , , "Essential ...

... , STAMFORD, Conn., Sept. 23 AmeriCares this ... States at the 2009 Clinton Global Initiative in New York ... CEO Curt Welling, is a two-year commitment to improve community ... organizations serving the uninsured and underinsured throughout the country. ...

... , , , ... announces their Second Annual Fellowship Convention to be held at ... California. , , Founded in 1998, FA is ... support, are recovering from food addiction. For many people who ...

... series of cases with commentaries by the American ... Rights Committee and the College,s Center for Ethics ... http://cme.medscape.com/viewpublication/30131. "The ethical dilemmas presented are very ... MD, FACP, ACP President. "Learning from case studies ...

... capsules that show a tendency in the standard laboratory test ... and potentially unsafe manner in patients who have consumed alcohol ... with testing in people. That,s the conclusion of a ... Molecular Pharmaceutics , a bi-monthly journal. In ...

Cached Medicine News:Health News:12 Local Athletes and Coaches Chosen for U.S. Wheelchair Basketball Team 2 Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 2 Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 3 Health News:AmeriCares Expands Medical Assistance Across the United States 2 Health News:AmeriCares Expands Medical Assistance Across the United States 3 Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 2 Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 3

12 Local Athletes and Coaches Chosen for U.S. Wheelchair Basketball Team Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference AmeriCares Expands Medical Assistance Across the United States Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World ACP launches ethics case studies series on MedscapeCME Medicinal products susceptible to 'dose dumping' should be fully tested

An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....

Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...

... Biotech Uni-Gold™ Pf Malaria Test is ... the presence of Plasmodium falciparum ... is an antigen-capture assay detecting presence ... rich protein II (PfHRP- II), which ...

High sensitive, specific one step immunochromatographic assay for human infectious disease...

Medicine Products:

PALUTOP+4 Malaria Device / Strip (3 line, PAN-pLDH, P.f.-HRP2)Rapid Uni-Gold™SD Malaria P.f. / P.v. Ag